MAP
MICROBA LIFE SCIENCES LIMITED
$0.0490
▼ -3.92%
Market cap
$35M
Turnover
$73,844
Last price
$0.0490
Day change
-3.92%
Announcements
15
Range, past year
Open 0.081 · Low 0.036 · Now 0.049 · High 0.225
Open MAP in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
MAP momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-09-28.
Momentum quality
26/100
Wyckoff phase
Downtrend15d
Trend stage
Breakdown
1 Day
-3.9%
1 Week
-2.0%
1 Month
-10.9%
1 Year
-39.5%
RSI
41
Avg daily range
6.4%
MICROBA LIFE SCIENCES LIMITED scores 26 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Breakdown.
On the Wyckoff cycle it sits in Downtrend, where it has been for 15 trading days. The weekly timeframe reads Downtrend, which agrees with the daily view.
Against the wider market it is currently underperforming and the institutional accumulation signal reads low.
Points to watch
- High volatility (ATR 6.4%)
- Thin liquidity
- Risk rating: Very High
- Composite downside risk elevated
Browse the whole market by signal:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highsMAP announcements
Recent price-sensitive releases.
- 2026-09-25 Appointment of Interim Chief Executive Officer CEO/Managing Director - Appointment Resignation | Company Administration - Other
- 2026-08-31 2026 Annual Report & Appendix 4E Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
- 2026-07-16 Q4 FY26 Quarterly Investor Presentation & Webinar
- 2026-07-16 Q4 FY26 Quarterly Activities Report & Appendix 4C
- 2026-06-19 Disclosure Document - Prospectus
- 2026-06-12 Investor presentation - path to cashflow breakeven
- 2026-06-12 Reinstatement to Quotation
More Health Care stocks
Most traded in the same sector.